Labcorp Holdings Inc
LH251.810USD
-2.860-1.12%
終値 01/09, 16:00（ET）15分遅れの株価
20.90B時価総額
24.56直近12ヶ月PER
詳細情報 Labcorp Holdings Inc 企業名
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Labcorp Holdings Incの企業情報
企業コードLH
会社名Labcorp Holdings Inc
上場日Apr 24, 1991
最高経営責任者「CEO」Schechter (Adam H)
従業員数70000
証券種類Ordinary Share
決算期末Apr 24
本社所在地358 S Main St
都市BURLINGTON
証券取引所NASDAQ OMX NASDAQ Basic NYSE
国United States of America
郵便番号27215
電話番号13362291127
ウェブサイトhttps://www.labcorp.com/
企業コードLH
上場日Apr 24, 1991
最高経営責任者「CEO」Schechter (Adam H)
Labcorp Holdings Incの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Adam H. Schechter
Mr. Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
87.57K
-5745.00%
Dr. Brian J. Caveney, M.D., J.D.
Dr. Brian J. Caveney, M.D., J.D.
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
30.07K
-2000.00%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Executive Vice President - Special Advisor, Strategy
Executive Vice President - Special Advisor, Strategy
22.53K
+1972.00%
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Independent Director
Independent Director
12.89K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Lead Independent Director
Lead Independent Director
12.84K
--
Ms. Kerrii B. Anderson, CPA
Ms. Kerrii B. Anderson, CPA
Independent Director
Independent Director
8.67K
-4000.00%
Ms. Amy B. Summy
Ms. Amy B. Summy
Executive Vice President, Chief Marketing Officer
Executive Vice President, Chief Marketing Officer
5.30K
+757.00%
Mr. Mark S. Schroeder
Mr. Mark S. Schroeder
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
4.96K
--
Mr. Akinbolade Oyegunwa
Mr. Akinbolade Oyegunwa
Executive Vice President and Chief Information and Technology Officer
Executive Vice President and Chief Information and Technology Officer
3.73K
+263.00%
Ms. Megan D. Bailey
Ms. Megan D. Bailey
Executive Vice President and President - Central Laboratories and International
Executive Vice President and President - Central Laboratories and International
3.59K
+191.00%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Adam H. Schechter
Mr. Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
87.57K
-5745.00%
Dr. Brian J. Caveney, M.D., J.D.
Dr. Brian J. Caveney, M.D., J.D.
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
30.07K
-2000.00%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Executive Vice President - Special Advisor, Strategy
Executive Vice President - Special Advisor, Strategy
22.53K
+1972.00%
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Independent Director
Independent Director
12.89K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Lead Independent Director
Lead Independent Director
12.84K
--
Ms. Kerrii B. Anderson, CPA
Ms. Kerrii B. Anderson, CPA
Independent Director
Independent Director
8.67K
-4000.00%
収益内訳
通貨: USD更新時刻: Wed, Mar 12
通貨: USD更新時刻: Wed, Mar 12
FY2021
FY2020
FY2019
会社から関連データがまだ開示されていません。
地域別USD
会社名
収益
比率
Northern America
13.09B
81.22%
Europe
2.05B
12.72%
Other Countries
976.40M
6.06%
事業別
地域別
会社から関連データがまだ開示されていません。
株主
更新時刻: Sun, Nov 16
更新時刻: Sun, Nov 16
株主統計
種類
株主統計
株主統計
比率
The Vanguard Group, Inc.
11.79%
BlackRock Institutional Trust Company, N.A.
5.30%
State Street Investment Management (US)
4.62%
Victory Capital Management Inc.
3.18%
Geode Capital Management, L.L.C.
2.56%
他の
72.54%
株主統計
株主統計
比率
The Vanguard Group, Inc.
11.79%
BlackRock Institutional Trust Company, N.A.
5.30%
State Street Investment Management (US)
4.62%
Victory Capital Management Inc.
3.18%
Geode Capital Management, L.L.C.
2.56%
他の
72.54%
種類
株主統計
比率
Investment Advisor
50.39%
Investment Advisor/Hedge Fund
38.82%
Research Firm
2.40%
Pension Fund
1.76%
Hedge Fund
1.61%
Bank and Trust
1.56%
Sovereign Wealth Fund
1.25%
Individual Investor
0.36%
Family Office
0.26%
他の
1.59%
機関投資家保有株
更新時刻: Thu, Jan 1
更新時刻: Thu, Jan 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
1803
80.86M
97.54%
-4.56M
2025Q3
1802
83.09M
100.23%
+765.81K
2025Q2
1825
81.46M
98.03%
-5.42M
2025Q1
1872
81.69M
97.58%
-5.17M
2024Q4
1872
81.10M
96.90%
-5.32M
2024Q3
1856
80.09M
95.55%
-6.82M
2024Q2
1876
81.29M
96.43%
-7.49M
2024Q1
1904
82.39M
97.73%
-8.65M
2023Q4
1947
83.11M
99.02%
-9.76M
2023Q3
1930
84.34M
99.29%
-7.18M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
The Vanguard Group, Inc.
9.78M
11.79%
-66.55K
-0.68%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
4.39M
5.3%
-10.58K
-0.24%
Sep 30, 2025
State Street Investment Management (US)
3.83M
4.62%
-31.13K
-0.81%
Sep 30, 2025
Victory Capital Management Inc.
2.64M
3.18%
+440.22K
+20.04%
Sep 30, 2025
Geode Capital Management, L.L.C.
2.12M
2.56%
+9.78K
+0.46%
Sep 30, 2025
Wellington Management Company, LLP
2.11M
2.54%
+289.03K
+15.91%
Sep 30, 2025
Allspring Global Investments, LLC
2.00M
2.41%
-4.51K
-0.23%
Sep 30, 2025
Select Equity Group, L.P.
1.84M
2.22%
-295.76K
-13.87%
Sep 30, 2025
Diamond Hill Capital Management Inc.
1.64M
1.98%
-181.26K
-9.94%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
1.25M
1.5%
-41.66K
-3.23%
Sep 30, 2025
詳細を見る
関連ETF
更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
iShares U.S. Healthcare Providers ETF
3.32%
Knowledge Leaders Developed World ETF
2.73%
Thrivent Small-Mid Cap ESG ETF
2.26%
State Street SPDR S&P Health Care Services ETF
1.9%
Schwab Ariel Opportunities ETF
1.62%
Brandes US Value ETF
1.56%
Invesco S&P 500 Equal Weight Health Care ETF
1.52%
Madison Covered Call ETF
1.49%
Nuveen ESG Mid-Cap Value ETF
1.4%
Franklin Genomic Advancements ETF
1.25%
詳細を見る
iShares U.S. Healthcare Providers ETF
比率3.32%
Knowledge Leaders Developed World ETF
比率2.73%
Thrivent Small-Mid Cap ESG ETF
比率2.26%
State Street SPDR S&P Health Care Services ETF
比率1.9%
Schwab Ariel Opportunities ETF
比率1.62%
Brandes US Value ETF
比率1.56%
Invesco S&P 500 Equal Weight Health Care ETF
比率1.52%
Madison Covered Call ETF
比率1.49%
Nuveen ESG Mid-Cap Value ETF
比率1.4%
Franklin Genomic Advancements ETF
比率1.25%
配当金
過去5年間の配当金総支払額は
692.30M
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
Oct 08, 2025
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Dec 11, 2025 going ex on Nov 26, 2025
Nov 26, 2025
Dec 11, 2025
Nov 26, 2025
Jul 10, 2025
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Sep 11, 2025 going ex on Aug 28, 2025
Aug 28, 2025
Sep 11, 2025
Aug 28, 2025
Apr 10, 2025
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Jun 11, 2025 going ex on May 29, 2025
May 29, 2025
Jun 11, 2025
May 29, 2025
Jan 09, 2025
LH.NB Final Cash Dividend of gross USD 0.72 paid on Mar 12, 2025 going ex on Feb 27, 2025
Feb 27, 2025
Mar 12, 2025
Feb 27, 2025
Oct 10, 2024
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Dec 13, 2024 going ex on Nov 26, 2024
Nov 26, 2024
Dec 13, 2024
Nov 26, 2024
Jul 25, 2024
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Sep 13, 2024 going ex on Aug 29, 2024
Aug 29, 2024
Sep 13, 2024
Aug 29, 2024
Apr 11, 2024
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Jun 12, 2024 going ex on May 24, 2024
May 28, 2024
Jun 12, 2024
May 24, 2024
Jan 12, 2024
LH.NB Final Cash Dividend of gross USD 0.72 paid on Mar 13, 2024 going ex on Feb 26, 2024
Feb 27, 2024
Mar 13, 2024
Feb 26, 2024
Oct 12, 2023
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Dec 12, 2023 going ex on Nov 07, 2023
Nov 08, 2023
Dec 12, 2023
Nov 07, 2023
Jul 13, 2023
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Sep 08, 2023 going ex on Aug 07, 2023
Aug 08, 2023
Sep 08, 2023
Aug 07, 2023
詳細を見る
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
よくある質問
Labcorp Holdings Incの上位5名の株主は誰ですか？
Labcorp Holdings Incの上位5名の株主は以下のとおりです。
The Vanguard Group, Inc.は9.78M株を保有しており、これは全体の11.79%に相当します。
BlackRock Institutional Trust Company, N.A.は4.39M株を保有しており、これは全体の5.30%に相当します。
State Street Investment Management (US)は3.83M株を保有しており、これは全体の4.62%に相当します。
Victory Capital Management Inc.は2.64M株を保有しており、これは全体の3.18%に相当します。
Geode Capital Management, L.L.C.は2.12M株を保有しており、これは全体の2.56%に相当します。
The Vanguard Group, Inc.は9.78M株を保有しており、これは全体の11.79%に相当します。
BlackRock Institutional Trust Company, N.A.は4.39M株を保有しており、これは全体の5.30%に相当します。
State Street Investment Management (US)は3.83M株を保有しており、これは全体の4.62%に相当します。
Victory Capital Management Inc.は2.64M株を保有しており、これは全体の3.18%に相当します。
Geode Capital Management, L.L.C.は2.12M株を保有しており、これは全体の2.56%に相当します。
Labcorp Holdings Incの株主タイプ上位3種は何ですか？
Labcorp Holdings Incの株主タイプ上位3種は、
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
Labcorp Holdings Inc（LH）の株式を保有している機関の数はいくつですか？
2025Q4時点で、Labcorp Holdings Incの株式を保有している機関は1803社あり、保有株式の総市場価値は約80.86Mで、全体の97.54%を占めています。2025Q3と比較して、機関の持ち株は-2.70%増加しています。
Labcorp Holdings Incの最大の収益源は何ですか？
FY2021において、--部門がLabcorp Holdings Incにとって最大の収益を生み出しており、その金額は--で、全収益の--%を占めています。
